Disentangling the Babylonian speech confusion in genetic counseling: An analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic

Genetics in Medicine

Volumn 11, Issue 10, 2009, Pages 742-749

  Vos, Joël ^a   Van Asperen, Christi J ^a   Wijnen, Juul T ^a   Stiggelbout, Anne M ^a   Tibben, Aad ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Genetic screening counseling; Guidelines; Oncology; Risk perception

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; CONTENT VALIDITY; DNA DETERMINATION; EMPIRICISM; GENETIC COUNSELING; HUMAN; MEDICAL LITERATURE; NOMENCLATURE; RELIABILITY; THEORETICAL STUDY; VALIDITY;

BREAST NEOPLASMS; COMMUNICATION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PERCEPTION; PHYSICIAN-PATIENT RELATIONS; REPRODUCIBILITY OF RESULTS; RISK; SPEECH; TERMINOLOGY AS TOPIC;

BABYLONIA;

EID: 70350221026     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181b2e608     Document Type: Article

References (29)

1. Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, Povey S. Guidelines for human gene nomenclature. Genomics 2002;79:464-470
2. Ad Hoc Committee on Mutation Nomenclature. Update on nomenclature for human gene mutations. Hum Mutat 1996;8:197-202.
3. Beutler E, McKusick VA, Motulsky AG, Scriver CR, Hutchinson F. Mutation nomenclature: nicknames, systematic names and unique identifiers. Hum Mutat 1996;8:202-206.
4. Antonarakis SE; the Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 1998;11:1-3.
5. Den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12.
6. Easton DF, Ford D, Bishop DT, et al. Breast and ovarian-cancer incidence in Brcai-mutation carriers. Am J Hum Genet 1995;56:265-271.
7. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-646.
8. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62:676-689.
9. Antoniou A, Pharoah PDP, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
10. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-1333.
11. Vink GR, van Asperen CJ, Devilee P, Breuning MH, Bakker E. Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines. Eur J Hum Genet 2004;13:525-527.
12. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Genet Test 2004;8:13-21.
13. Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002;6:79-87.
14. Bish A, Sutton S, Jacobs C, Levene S, Ramirez A, Hodgson S. No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches. Genet Med 2002;4:353-358.
15. Kelly K, Leventhal H, Andrykowski M, et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psychooncology 2005;14:34-48.
16. Vos J, Otten W, van Asperen CJ, Jansen A, Menko FH, Tibben A. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation and impact on life. Psychooncology 2008;17:822-830.
17. Dorval M, Gauthier G, Maunsell E, et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev. 2005;14:2862-2867.
18. van Dijk S, Otten W, Timmermans DR. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 2005;7:239-245.
19. Easton DF, Deffenbaugh AM, Pruss D, et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 2007;81:873-883.
20. Plon SE, Eccles DM, Easton D, et al. Sequence variant classification ands reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 2008;29:1282-1291.
21. Lubin IM, McGovern MM, Gibson Z, et al. Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn 2009;11:162-171.
22. Sapir A. selected writings of Edward Sapir in language, culture, and personality. California: University of California Press, 1983.
23. Putnam H. The meaning of 'meaning.' In: Putnam H, editor. Philosophical papers: Vol.2. Mind, language and reality. Cambridge, England: Cambridge University Press, 1975:215-271.
24. Rorty R. Philosophy and the mirror of nature. Princeton: Princeton University Press, 1980.
25. Whorf B. Language, thought, and reality: selected writings of Benjamin Lee Whorf. New York: MIT Press, 1956.
26. Lakoff G. The contemporary theory of metaphor. In: Ortony A, editor. Metaphor and thought, 2nd ed. New York: Cambridge University Press, 1993:202-251.
27. Bromme R, Rambow R, Nückles M. Expertise and estimating what other people know: the influence of professional experience and type of knowledge. J Exp Psychol Appl 2001;7:317-330.
28. Nickerson RS. How we know-and sometimes misjudge-what others know: imputing one's own knowledge to others. Psychol Bull 1999;125: 737-759.
29. Lasset C, Charavel M, Bonadona V. Focus groups approach for developing written patient information in oncogenetics. Genet Test 2007;11:193-197.